1-3 of 3
Nicholas Fisher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Clinical Trials & Observations
Steven M. Devine, Ravi Vij, Michael Rettig, Laura Todt, Kiley McGlauchlen, Nicholas Fisher, Hollie Devine, Daniel C. Link, Gary Calandra, Gary Bridger, Peter Westervelt, John F. DiPersio
Journal: Blood
Blood (2008) 112 (4): 990–998.
https://doi.org/10.1182/blood-2007-12-130179
Published: 2008
Journal Articles

HLA-Matched Sibling Donor Stem Cell Mobilization Can Be Safely and Effectively Reduced from a Five Day to a One Day Process by a Direct Antagonist of the CXCR4/SDF-1 Interaction.

Steven M. Devine, MD, Ravi Vij, MD, Laura Todt, RN, Kiley McLaughlin, BS, Nicholas Fisher, BA, Natalie Morris, Daniel C. Link, MD, Gary Calandra, MD, Gary Bridger, PhD, John F. DiPersio, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 53.
https://doi.org/10.1182/blood.V108.11.53.53
Published: 2006
Journal Articles

A Phase I Pharmacokinetic Trial of Decitabine Administered as a 3-Hour Infusion to Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS).

Amanda Cashen, MD, Ajit Shah, PhD, Angela Helget, Laura Todt, Nicholas Fisher, John DiPersio, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1854.
https://doi.org/10.1182/blood.V106.11.1854.1854
Published: 2005